Citation Impact
Citing Papers
Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
2012
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
2014
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
2015 StandoutNobel
Ischemia and reperfusion—from mechanism to translation
2011 Standout
State of the art paper Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis – emerging perspectives of immunomodulation
2013
Targeting hypoxia in cancer therapy
2011 Standout
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
2011 Standout
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
2011 Nature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
MYC on the Path to Cancer
2012 Standout
Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis
2011 StandoutNobel
Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice
2008
Nucleotide signalling during inflammation
2014 StandoutNature
Chronic inflammation in the etiology of disease across the life span
2019 Standout
A guide to immunometabolism for immunologists
2016 Standout
Adaptive immunity in atherogenesis: new insights and therapeutic approaches
2013
Deciphering and Reversing Tumor Immune Suppression
2013
A tale of two plaques: convergent mechanisms of T‐cell‐mediated inflammation in psoriasis and atherosclerosis
2011
Hypoxia and Inflammation
2011 Standout
Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions
2007
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
2009
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
2011
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Psoriasis
2015 Standout
The immune system in atherosclerosis
2011 Standout
The immunology of atherosclerosis
2017
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
2012
Adaptive immunity and atherosclerosis
2009
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis
2011
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
2021
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Targeting autophagy in cancer
2017 Standout
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy
2010
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
2012
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
2013
Stabilisation of atherosclerotic plaques
2011
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Development and Maintenance of Regulatory T cells
2013 StandoutNobel
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
2012
Roles of Purinergic Receptor P2Y, G Protein–Coupled 12 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
2012
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
2014 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Hypoxia. 5. Hypoxia and hematopoiesis
2011
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
2011
Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice
2009
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Oral Administration of an Active Form of Vitamin D 3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions
2010
Works of Adi Mor being referenced
Decreased Secretion of Th2 Cytokines Precedes Up-regulated and Delayed Secretion of Th1 Cytokines in Activated Peripheral Blood Mononuclear Cells from Patients with Insulin-Dependent Diabetes Mellitus
1998
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
2007
Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1α
2008
Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice
2009
Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental Atherosclerosis
2007